Koutras, Angelos
Zagouri, Flora
Koliou, Georgia-Angeliki
Psoma, Elizabeth
Chryssogonidis, Ioannis
Lazaridis, Georgios
Tryfonopoulos, Dimitrios
Kotsakis, Athanasios
Res, Eleni
Kentepozidis, Nikolaos K.
Razis, Evangelia
Psyrri, Amanda
Koumakis, Georgios
Kalofonos, Haralabos P.
Dimopoulos, Meletios A.
Fountzilas, George
Article History
Received: 4 September 2019
Revised: 22 April 2020
Accepted: 6 May 2020
First Online: 3 June 2020
Ethical approval and consent to participate
: All patients provided written informed consent before participating in the study. The clinical protocol was approved by the Institutional Review Boards in the participating Centers, by the National Organization for Medicines and by the National Ethics Committee and was registered in international databases (ClinicalTrials.gov NCT01693549, EudraCT 2011-003625-97). The study was conducted in accordance with the ethical principles that have their origins in the Declaration of Helsinki.
: NA
: All data are available upon request.
: A.K.: Consulting or advisory role: Roche, Genesis, Astra-Zeneca. Travel: Sanofi-Aventis, Astellas, Genesis, Amgen, BMS, Merck Serono. G.L.: Honoraria: BMS, Roche, Merck, MSD, Advisory Role: Merck, Travel: BMS. E.R.: Consulting or advisory role: Novartis; Honoraria: Novartis; Travel: Genesis Pharmaceuticals, Pfizer, Roche, Bristol-Myers Squibb, Genekor. A.P.: Consulting or advisory role: Amgen, Merck Serono, Roche, BMS, Astra-Zeneca, MSD, Honoraria: Amgen, Merck Serono, Roche, BMS, Astra-Zeneca, MSD. Research funds: BMS Kura. M.A.D.: Advisory: Celgene, Janssen, Takeda, Amgen, Honoraria: Celgene, Janssen, Takeda, Amgen. G.F.: Advisory Board of Pfizer, Sanofi and Roche. Honoraria from Astra-Zeneca.
: The study was supported by Sanofi. The funders played no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.